Hypertension Diagnostics, Inc.
HDII
$0.00
$0.000.00%
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -11,325.00% | 80.10% | 27.89% | -110.15% | 105.48% |
| Total Depreciation and Amortization | 18.88% | 22.67% | -- | -- | -- |
| Total Amortization of Deferred Charges | 255.78% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 146.80% | -191.93% | -63.53% | -85.92% | -11,724.00% |
| Change in Net Operating Assets | 133.83% | 142.69% | 735.57% | 80,818.18% | -23,736.36% |
| Cash from Operations | 71.18% | 57.41% | -102.98% | 277.11% | -642.89% |
| Capital Expenditure | -27.32% | 85.94% | 67.35% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.47% | -- | -- | 200.00% | -- |
| Cash from Investing | -5.19% | 84.68% | -204.67% | 200.00% | -- |
| Total Debt Issued | -70.47% | -41.61% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -71.70% | -43.59% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.17% | 86.99% | 103.15% | -350.29% | 383.81% |
